Segregation analysis in Shwachman-Diamond syndrome: evidence for recessive inheritance.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 1288206)

Published in Am J Hum Genet on March 14, 2000

Authors

H Ginzberg1, J Shin, L Ellis, S Goobie, J Morrison, M Corey, P R Durie, J M Rommens

Author Affiliations

1: Division of Gastroenterology and Nutrition, Hospital for Sick Children, Toronto, Canada.

Articles cited by this

A simple method of estimating the segregation ratio under complete ascertainment. Am J Hum Genet (1968) 2.62

Shwachman's syndrome. A review of 21 cases. Arch Dis Child (1980) 2.32

The 'singles' method for segregation analysis under incomplete ascertainment. Ann Hum Genet (1979) 1.67

Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47

An inherited defect of neutrophil mobility in Shwachman syndrome. J Pediatr (1979) 1.42

Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology (1996) 1.25

The syndrome of exocrine pancreatic insufficiency, neutropenia, metaphyseal dysostosis and dwarfism. Helv Paediatr Acta (1969) 1.17

Simple segregation analysis: a review of its history and terminology. J Hered (1983) 0.95

Increased paternal age in CHARGE association. Clin Genet (1996) 0.93

Births in Canada, 1992. Health Rep (1993) 0.91

High parental age is associated with sporadic hereditary retinoblastoma: the Dutch retinoblastoma register 1862-1994. Hum Genet (1996) 0.90

Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis. Gut (1986) 0.87

Impaired natural killer cell recycling in childhood chronic neutropenia with morphological abnormalities and defective chemotaxis of neutrophils. Blood (1985) 0.86

Aberrant phagocyte function in Shwachman syndrome. Clin Exp Immunol (1987) 0.85

Shwachman syndrome associated with de novo reciprocal translocation t(6;12)(q16.2;q21.2). J Med Genet (1995) 0.81

Exclusion of linkage of Shwachman-Diamond syndrome to chromosome regions 6q and 12q implicated by a de novo translocation. Am J Med Genet (1999) 0.81

Changing paternal age distribution and the human mutation rate in Europe. Hum Genet (1990) 0.79

Articles by these authors

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 40.22

Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61

Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87

The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell (1985) 7.45

Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature (1995) 6.16

The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet (1993) 5.97

Prediction of mortality in patients with cystic fibrosis. N Engl J Med (1992) 5.46

Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74

The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70

De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet (1997) 4.65

Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature (1985) 3.75

Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70

Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet (1998) 3.62

TOPAS: an innovative proton Monte Carlo platform for research and clinical applications. Med Phys (2012) 3.57

Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell (1991) 3.56

Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet (1996) 3.50

MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res (1997) 3.38

p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem (1996) 3.27

Multi-ion pore behaviour in the CFTR chloride channel. Nature (1993) 3.14

Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol (2000) 2.93

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A (1998) 2.80

The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med (1995) 2.49

Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet (1992) 2.48

ATPase activity of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1996) 2.33

Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9- and 10-year-old girls. J Am Diet Assoc (1994) 2.30

Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum Mol Genet (1996) 2.29

Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr (1990) 2.28

A prospective longitudinal study of social, psychological and obstetric factors in pregnancy: response rates and demographic characteristics of the 8556 respondents. Br J Obstet Gynaecol (1989) 2.27

Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J Gen Physiol (1997) 2.26

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med (1984) 2.22

Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther (2010) 2.21

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma. Proc Natl Acad Sci U S A (2007) 2.10

Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07

Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 2.07

Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis (1976) 2.03

Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther (2009) 1.99

Ethics approval for research in medical education. Med Educ (2001) 1.96

Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A (1998) 1.93

A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr (2000) 1.93

Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem (2001) 1.86

Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.80

Improving prevention systems in primary care practices: the Health Education and Research Trial (HEART) J Fam Pract (2000) 1.78

Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med (1989) 1.77

Role of conventional physiotherapy in cystic fibrosis. J Pediatr (1988) 1.75

Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology (1988) 1.75

Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. Proc Natl Acad Sci U S A (1996) 1.73

The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat Genet (1993) 1.72

Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70

The HIV information project for transfusion recipients a decade after transfusion. Arch Pediatr Adolesc Med (1995) 1.70

DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet (1989) 1.66

Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1985) 1.66

Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics (1990) 1.65

Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr (2005) 1.64

Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr (1982) 1.64

Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology (2000) 1.63

Nerve growth cones isolated from fetal rat brain: subcellular fractionation and characterization. Cell (1983) 1.62

Intussusception in an adult patient with severe hyperglycaemia--a case report. Diabet Med (2002) 1.51

High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med (1997) 1.51

Energy expenditure of patients with cystic fibrosis. J Pediatr (1987) 1.51

Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut (1980) 1.50

Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet (1999) 1.50

Arbor 3D: an interactive environment for examining phylogenetic and taxonomic trees in multiple dimensions. Bioinformatics (2000) 1.50

Use of high-fat formula for premature infants with bronchopulmonary dysplasia: metabolic, pulmonary, and nutritional studies. J Pediatr (1994) 1.50

Acute pancreatitis in childhood. J Pediatr (1988) 1.49

Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene? Clin Genet (2009) 1.47

CFTR gene variant for patients with congenital absence of vas deferens. Am J Hum Genet (1995) 1.47

Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47

Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut (2003) 1.45

Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM (2007) 1.45

Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr (1989) 1.45

A position paper of the North American Society for Pediatric Gastroenterology and Nutrition. Pediatric gastroenterology Workforce Survey and future supply and demand. J Pediatr Gastroenterol Nutr (1998) 1.45

Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut (1986) 1.44

Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J Biol Chem (1996) 1.41

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation (1984) 1.41

Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics (1996) 1.41

Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet (1999) 1.41

A physical and transcriptional map of the preaxial polydactyly locus on chromosome 7q36. Genomics (1999) 1.40

Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr (1989) 1.37

The regulatory role of known tyrosine autophosphorylation sites of the insulin receptor kinase domain. An assessment by replacement with neutral and negatively charged amino acids. J Biol Chem (1991) 1.35

Neural control of the lower urinary tract: peripheral and spinal mechanisms. Neurourol Urodyn (2010) 1.35

Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res (1986) 1.34

Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc Natl Acad Sci U S A (1994) 1.34

Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33

The mental health of women 6 months after they give birth to an unwanted baby: a longitudinal study. Soc Sci Med (1991) 1.33

Role of infant feeding practices in development of Crohn's disease in childhood. BMJ (1989) 1.32

Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol (1989) 1.31

Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr (1985) 1.30

Autophosphorylation activates the soluble cytoplasmic domain of the insulin receptor in an intermolecular reaction. J Biol Chem (1989) 1.30

DNA amplification for detection of the XV-2c polymorphism linked to cystic fibrosis. Nucleic Acids Res (1989) 1.29

Development of a routine method for the determination of trace metals in whole blood by magnetic sector inductively coupled plasma mass spectrometry with particular relevance to patients with total hip and knee arthroplasty. Clin Chem (2001) 1.28

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr (1999) 1.28